Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL

Table 2 RNA sequencing results of mRNA from the LPCs and other cells fractions in patients with de novo Ph⁺ALL

Sample ID^a	Clean reads, M^b	Mapping rate, %^c	Exons, %	Intron, %	Intergenic, %
LPC₁	60	83.6	81.1	16.1	2.8
LPC₂	56	84.4	77.0	19.6	3.4
Other Cell₁	68	84.6	91.3	7.3	1.5
Other Cell₂	74	83.8	87.7	10.4	1.9

^aLPC₁, LPC₂ and Other Cell₁, Other Cell₂ are replicate from the LPCs and other cell groups
^bIndicates millions of reads
^cUses the Sus scrofa 10.2 as the reference genome annotation to classify the mapping tags into the different regions. Ratio was calculated by the number of tags on each region divided by the total tags on the whole genome

ISSN: 1479-5876